Online Inquiry
  •  

SIGLEC9 gRNA Lentiviral Particle for Macrophage Engineering (MTS-0124-LX34)

Overview

Description
The pre-made SIGLEC9 gRNA Lentiviral Particle is packaged using 3rd generation of lentiviral packaging system, serving as a convenient tool to support macrophage cell engineering.
Product Type
Virus Particles
Application Scenario
For in vivo and in vitro macrophage engineering

Target Specification

Engineering Approach
Target KO gRNA Contruction Lentivirus
Species
Human
Target
SIGLEC9 gRNA
Alternative Names
CD329; CDw329; FOAP-9; siglec-9; OBBP-LIKE
Full Name
Sialic acid binding Ig like lectin 9
Introduction
Predicted to enable monosaccharide binding activity and sialic acid binding activity. Predicted to be involved in cell adhesion. Predicted to act upstream of or within negative regulation of inflammatory response and negative regulation of phagocytosis, engulfment. Predicted to be located in external side of plasma membrane. Predicted to be active in plasma membrane.
UniprotID
GeneID
Applications
Promote the macrophage capability of limiting tumor growth
Reference
Mantovani, Alberto et al. "Macrophages as tools and targets in cancer therapy." Nature reviews. Drug discovery vol. 21,11 (2022): 799-820. doi:10.1038/s41573-022-00520-5

Product Specification

Packaging System
Lentivirus
Titer
>1E8 TU/mL
Size
200uL; 1mL
Mycoplasma Testing
Negative
Sterility Testing
Negative
Shipping
Dry ice
Storage
Stored at -80°C for long term.
Handling Notes
Avoid multiple freeze/thaw cycles.
Restriction
RUO

For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.

CONTACT US
(USA)
(UK)
(Germany)
ADDRESS

> Global

ISO 9001 Certified - Creative Biolabs Quality Management System.

Copyright © 2024 Creative Biolabs. All Rights Reserved.